Will Democrats in Congress keep the door open for pharma — or slam it?

Will Democrats in Congress keep the door open for pharma — or slam it?

The drug industry is headed back to Congress to make its case. Will Democrats keep the door open?

By NICHOLAS FLORKO

MIKE REDDY FOR STAT

Current and former staffers and lobbyists connected to the industry said PhRMA is struggling to preserve its clout as Democrats take control of the House.

READ MORE